BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7491579)

  • 1. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology].
    Cordonnier D; Vert-Pré FC; Bayle F; Alix JL; Couderc P
    Nephrologie; 1985; 6(1):19-26. PubMed ID: 3923381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C and 5-fluorouracil as second choice treatment in advanced breast cancer patients.
    Ardizzoni A; Pronzato P; Conte PF; Rosso R
    Chemioterapia; 1984 Apr; 3(2):83-5. PubMed ID: 6442624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intra-arterial chemotherapy in locally advanced or recurrent breast neoplasms].
    Morandi C; Colopi S; Cantore M; Molani L; Calzona C; Reggiani G; Amadori M; Smerieri F; Pellecchi G
    Radiol Med; 1996; 92(1-2):101-4. PubMed ID: 8966246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.
    Crocker J; Jones EL
    J Clin Pathol; 1983 Jan; 36(1):24-9. PubMed ID: 6401771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C-induced pulmonary and renal toxicities.
    Loprinzi CL
    Wis Med J; 1984 Mar; 83(3):16-7. PubMed ID: 6428065
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
    Mergenthaler HG; Binsack T; Wilmanns W
    Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two patients with a fatal haemolytic-uremic syndrome after combination therapy including mitomycin C.
    Boven E; Pinedo HM
    Neth J Med; 1983; 26(9):288. PubMed ID: 6419135
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uremic hemolytic syndrome induced by mitomycin C. Presentation of a series of 5 cases and review of the literature].
    Nicolás JM; Villalta J; González-Clemente JM; Antúnez E; Almirall J; Bosch J; Torras A; Urbano-Márquez A
    Rev Clin Esp; 1990 Mar; 186(4):166-70. PubMed ID: 2114657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitomycin-induced hemolytic uremic syndrome: case presentation and review of literature.
    Rabadi SJ; Khandekar JD; Miller HJ
    Cancer Treat Rep; 1982 May; 66(5):1244-7. PubMed ID: 7083229
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE; Phillips TM; Schein PS
    J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three cases of drug-induced hemolytic uremic syndrome].
    Tohda S; Shiigai T; Jibiki M; Aoi T; Ueda Y; Kawasaki T; Kurokawa H; Nara N
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):361-4. PubMed ID: 8712831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
    Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
    Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic-uremic syndrome caused by mitomycin c: long-term management].
    Duvic C; Sarret D; Coutant G; Herody M; Didelot F; Nedelec G
    Ann Med Interne (Paris); 2000 Feb; 151(1):70-3. PubMed ID: 10761566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary angiomatoid vascular changes in mitomycin C-associated hemolytic-uremic syndrome.
    Chang-Poon VY; Hwang WS; Wong A; Berry J; Klassen J; Poon MC
    Arch Pathol Lab Med; 1985 Sep; 109(9):877-8. PubMed ID: 3927871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitomycin-induced hemolytic-uremic syndrome].
    Zeller G; Wandel E; Schwarting A
    Dtsch Med Wochenschr; 2003 Jun; 128(25-26):1399-402. PubMed ID: 12813674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line and salvage therapy of metastatic breast cancer with mitomycin/vinblastine.
    Sedlacek SM
    Oncology; 1993 Apr; 50 Suppl 1():16-21. PubMed ID: 8483557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.